sulotroban has been researched along with Coronary Thrombosis in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (50.00) | 18.7374 |
| 1990's | 2 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Martin, U; Sponer, G; Strein, K | 1 |
| De Clerck, F; Hemans, C; Van Ammel, K; Van de Water, A; Vandeplassche, G; Wouters, L; Xhonneux, R | 1 |
| Berk, L; van der Giessen, WJ; Verdouw, PD; Zijlstra, FJ | 1 |
| Bugelski, PJ; Granett, JR; Shebuski, RJ; Smith, JM; Storer, BL | 1 |
4 other study(ies) available for sulotroban and Coronary Thrombosis
| Article | Year |
|---|---|
Hirudin and sulotroban improve coronary blood flow after reperfusion induced by the novel recombinant plasminogen activator BM 06.022 in a canine model of coronary artery thrombosis.
Topics: Animals; Coronary Circulation; Coronary Thrombosis; Dogs; Drug Therapy, Combination; Fibrinolytic Agents; Hirudin Therapy; Myocardial Reperfusion; Recombinant Proteins; Sulfonamides; Thrombolytic Therapy; Tissue Plasminogen Activator | 1992 |
Differential effects of thromboxane A2 synthase inhibition, singly or combined with thromboxane A2/prostaglandin endoperoxide receptor antagonism, on occlusive thrombosis elicited by endothelial cell injury or by deep vascular damage in canine coronary ar
Topics: Animals; Coronary Thrombosis; Coronary Vessels; Dogs; Endothelium, Vascular; Female; Hemodynamics; In Vitro Techniques; Male; Pentanoic Acids; Pyridines; Receptors, Prostaglandin; Receptors, Thromboxane; Sulfonamides; Thromboxane A2; Thromboxane-A Synthase | 1991 |
The effect of the thromboxane receptor antagonist BM 13.177 on experimentally induced coronary artery thrombosis in the pig.
Topics: Animals; Anti-Arrhythmia Agents; Aspirin; Coronary Disease; Coronary Thrombosis; Electric Stimulation; Hemodynamics; In Vitro Techniques; Platelet Aggregation; Receptors, Prostaglandin; Receptors, Thromboxane; Sulfonamides; Swine; Thromboxane B2 | 1988 |
Influence of selective endoperoxide/thromboxane A2 receptor antagonism with sulotroban on lysis time and reocclusion rate after tissue plasminogen activator-induced coronary thrombolysis in the dog.
Topics: Animals; Blood Pressure; Coronary Circulation; Coronary Disease; Coronary Thrombosis; Dogs; Drug Therapy, Combination; Female; Fibrinolytic Agents; Male; Platelet Aggregation Inhibitors; Sulfonamides; Thromboxane A2; Tissue Plasminogen Activator | 1988 |